{"name":"Bionano Genomics","slug":"bionano","ticker":"BNGO","exchange":"NASDAQ","domain":"bionanogenomics.com","description":"Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, ","hq":"San Diego, CA","founded":0,"employees":"95","ceo":"Erik Holmlin","sector":"Genomics / Diagnostics","stockPrice":1.17,"stockChange":0,"stockChangePercent":0,"marketCap":"$13M","metrics":{"revenue":32000000,"revenueGrowth":-2.6,"grossMargin":46.2,"rdSpend":11374000,"netIncome":-26395000,"cash":19269000,"dividendYield":0,"peRatio":-1,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Bionano Genomics Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Bionano Genomics reported its fourth quarter and full year 2023 financial results, with revenue of $13.4 million and a net loss of $24.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Bionano Genomics Announces Collaboration with Invitae to Develop Next-Generation Genome Analysis","summary":"Bionano Genomics announced a collaboration with Invitae to develop next-generation genome analysis using Saphyr.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxPd0tORi1IX2ppTGxuOE9sbE54SnRDUnVDM1h0X1NodEZ2eG9SZFh1dkF5VktGcER5RWxnMzMyczc5Rmg1ZTBmZmZNSThaS1lDYS1rSU9OWVppeUFZTndCVVFFR1pXVF9CTUowWm5xcGNLbFNTbnhFQVhxYkF1VWFPY3VldVRMc2VSSGdwcmk2Ukt3cUJlSWpiSC02LWRQbWVMUVRiWWFtd29PYmNUNUpqNzVjYjI1cno4UHJuV1ZDRElPbmZRcmJJQk1sN1FjU1BFclFTQ0ptd2RXSXhZTFJyQXlWMnNwYW1BT1lMZmhyR3ZVdUVxcElsZ196RG1VNENUOWJJbWFQUWtyVjhpOTduZHZHYmtwejhtMUgyeFhTOTZpdw?oc=5","date":"2026-04-04","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO) - The Globe and Mail","headline":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO)","sentiment":"neutral"},{"date":"2026-03-23","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-30","type":"earnings","source":"simplywall.st","summary":"Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues - simplywall.st","headline":"Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOU1ZTSW1TdXNaOXJITWJ0MTlHOXdDRkVwR19zaTl2MV82SWNWeGxzb29LeEhPZ2hqYlhNVW5fYnpGVnY4c1VRZ1Q1VnVvNVcyQ3h1YnBmTUxLdkZ2V25FX092QVhNVHlpYU91ZF9Ta2QtcjMwR0pLU2d1VTJFZkhjTXZtY29xZw?oc=5","date":"2026-01-03","type":"pipeline","source":"Nanalyze","summary":"5 Biotech Stocks We Like in 2026. And 5 We Don’t - Nanalyze","headline":"5 Biotech Stocks We Like in 2026. And 5 We Don’t","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-16","type":"earnings","source":"simplywall.st","summary":"Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations - simplywall.st","headline":"Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPZDM3RG1GZ2FjWVF1TWQ4Uk9VR2J2MmpGNkhCZGxYd0t2eC1PNVlUSnlDQnk1WmxoZW1tbng3YlIycjFKbkhGVUZXXzNZY3lUa2Z6Qlp2UXg0djhHUFVmM055a2xPTGJFZElJbmlTNFhHdmpqYmRxMUp2WjNuN2g2U0RNbEk1SlppcjNfeg?oc=5","date":"2023-07-24","type":"pipeline","source":"Seeking Alpha","summary":"Bionano Genomics: A Noble Cause But A Bad Investment (BNGO) - Seeking Alpha","headline":"Bionano Genomics: A Noble Cause But A Bad Investment (BNGO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNSEZ6dWFteGJvSDhmbEE1TVFEYjEzWWdrUEZ2aUxwOFJDQzh5NEg3T2tyVlNicTk5TUhYdlF6NjE0M2xKM1ptZGdtSlFKVWlHWVpmTkRNRW9yNU9IS0ttam55S1UtVm0wdWpZM2dGSU5LNUlaQS1HRENNMTJ5SmFMVC16TFU1N19teGlLSm1fN0Z4SUR2d0E?oc=5","date":"2023-05-06","type":"pipeline","source":"The Motley Fool","summary":"Better Gene Sequencing Stock: Illumina vs. Bionano Genomics - The Motley Fool","headline":"Better Gene Sequencing Stock: Illumina vs. Bionano Genomics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPaVh3OUR2dWszb1hIb29GS3hUTDFUVUVHWkp0WWhjSHFab2p3aC1pQy1VVjE2cFJxc0FxTE10X21xcFZsb2I5SGY0YnYwS2tVYjQ1aUxvRmRNWUI5MGtzRTdQZ01iWHdPdWx3Y2FtVVBmWW85V3dhSWsxb0w4dEQ3M1BMVXhIVTNzZWxjTUhIQnJqUW52NUlR?oc=5","date":"2022-04-27","type":"pipeline","source":"The Motley Fool","summary":"3 Moonshot Stocks With Upside of Up to 709%, According to Wall Street - The Motley Fool","headline":"3 Moonshot Stocks With Upside of Up to 709%, According to Wall Street","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE90T3NnSW9MamlueUVUZHQ5WC1WZm9MZHVhR3Ixbmlndi0zQ09xLWMtYkZuQUstNXNaWTVsVVQ5Z0t4cHRHNUdSVGo3TTRtN3ZaRDZKUDRXeDdWWXd4NVpydTNTdnAwaTMwOVdzV01yNVNGTnUzN3I2THlR?oc=5","date":"2021-06-15","type":"deal","source":"InvestorPlace","summary":"7 A-Rated Biotech Stocks to Buy Now - InvestorPlace","headline":"7 A-Rated Biotech Stocks to Buy Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNTGRJVnQwd3pMOUhBbExjWng0NDRYMEhIOHc3LWhQLTJRQm0zZ2hRWEI2bTFfMWJadHFBbUlJTFY0SDA0M3dBcHBvU2o5ZW1CcE1tR3ZRd1pNOEs2elJ3Q2ZyMWZJREZpWTBvUGJ2WHVSWGw3dWtHQUhyVVNRVmxheHctN3I?oc=5","date":"2021-05-14","type":"pipeline","source":"InvestorPlace","summary":"7 Reddit Penny Stocks That Are Promising to Cure Cancer - InvestorPlace","headline":"7 Reddit Penny Stocks That Are Promising to Cure Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE5jV3RublRnZUMxN3pWX3lQTWNqVG9TVWhlbG15UFN6NDFMaFcyS2s3UUstU0stWXZOdXVuc3dyZHNuV0YtNnFrWEpoQWJXaHlsMlF6d3o1VGxYZw?oc=5","date":"2018-09-25","type":"pipeline","source":"MarketBeat","summary":"Bionano Genomics (BNGO) Stock Price, News & Analysis - MarketBeat","headline":"Bionano Genomics (BNGO) Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Illumina","Thermo Fisher Scientific","Pacific Biosciences"],"therapeuticFocus":["Genomics","Diagnostics"],"financials":{"source":"sec_edgar","revenue":12000735,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":12000735,"period":"2018-12-31"},{"value":4013537,"period":"2018-12-31"},{"value":2828704,"period":"2018-09-30"},{"value":3390009,"period":"2018-06-30"},{"value":1768485,"period":"2018-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":11374000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-26395000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":73584000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1.17,"previousClose":1.17,"fiftyTwoWeekHigh":5.5,"fiftyTwoWeekLow":1.06,"fiftyTwoWeekRange":"1.06 - 5.5","fiftyDayAverage":1.19,"twoHundredDayAverage":2.11,"beta":1.6,"enterpriseValue":10380800,"forwardPE":-1,"priceToBook":0.28,"priceToSales":0.45,"enterpriseToRevenue":0.36,"enterpriseToEbitda":-0.44,"pegRatio":0,"ebitda":-23812000,"ebitdaMargin":-83.5,"freeCashflow":-4575125,"operatingCashflow":-16345000,"totalDebt":16894000,"debtToEquity":38,"currentRatio":1.98,"returnOnAssets":-27.7,"returnOnEquity":-66.2,"analystRating":"1.5 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":2,"targetMeanPrice":5.5,"targetHighPrice":7,"targetLowPrice":4,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":7.7,"institutionHeldPercent":10.6,"sharesOutstanding":11092000,"floatShares":9959507,"sharesShort":1089816,"shortRatio":10.74,"shortPercentOfFloat":10.2,"epsTrailing":-4.85,"epsForward":-1.11,"revenuePerShare":5.24,"bookValue":4.14,"officers":[{"age":57,"name":"Dr. Robert Erik Holmlin M.B.A., Ph.D.","title":"President, CEO, CFO & Director"},{"age":51,"name":"Mr. Mark  Oldakowski","title":"Chief Operating Officer"},{"age":52,"name":"Dr. Alka  Chaubey FACMG, Ph.D.","title":"Chief Medical Officer"},{"age":44,"name":"Mr. Mark  Adamchak CPA","title":"VP of Accounting & Controller"},{"age":50,"name":"Mr. Jonathan  Dixon J.D.","title":"General Counsel & Secretary"},{"age":null,"name":"Mr. Cory  Kreeck","title":"Global Head of People Operations"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://bionano.com","phone":"858 888 7600"}}